Multifunctional nanoplatform with near-infrared triggered nitric-oxide release for enhanced tumor ferroptosis
Authors:
Open Access
- 26 October 2024
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-16
Abstract
Ferroptosis has emerged as a promising strategy for cancer treatment. Nevertheless, the efficiency of ferroptosis-mediated therapy remains a challenge due to high glutathione (GSH) levels and insufficient endogenous hydrogen peroxide in the tumor microenvironment. Herein, we presented a nitric-oxide (NO) boost-GSH depletion strategy for enhanced ferroptosis therapy through a multifunctional nanoplatform with near-infrared (NIR) triggered NO release. The nanoplatform, IS@ATF, was designed that self-assembled by loading the NO donor L-arginine (L-Arg), ferroptosis inducer sorafenib (SRF), and indocyanine green (ICG) onto tannic acid (TA)-Fe3+‒metal-phenolic networks (MPNs) modified with hydroxyethyl starch. Inside the tumor, SRF could inhibit GSH biosynthesis, impair the activation of glutathione peroxidase 4, and disrupt the ferroptosis defensive system. In conjunction with TA-Fe3+‒MPNs, which has cascaded Fenton catalytic activity, it could navigate the lethal ferroptosis to cancer cells. Upon NIR laser irradiation, the ICG-generated ROS oxidated L-Arg to a substantial quantity of NO, which further depleted the intracellular GSH and caused LPO accumulation, enhancing cell ferroptosis. Moreover, ICG also serves as a photothermal agent that can produce hyperthermia when exposed to irradiation, further potentiating ferroptosis therapy. In addition, the nanoplatform showed significantly improved tumor therapeutic efficacy and anti-metastasis efficiency. This work thus demonstrated that utilizing NO boost-GSH depletion to enhance ferroptosis induction is a feasible and promising strategy for cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82303821)
- Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences (2023BP0103, 2024BP0201)
This publication has 48 references indexed in Scilit:
- Development of Polymethine Dyes for NIR‐II Fluorescence Imaging and TherapyAdvanced Healthcare Materials, 2024
- Biodegradable Ferric Phosphate Nanocarriers with Tumor‐Specific Activation and Glutathione Depletion for Tumor Self‐Enhanced Ferroptosis and ChemotherapyAdvanced Functional Materials, 2024
- An AND Logic Gate for Magnetic‐Resonance‐Imaging‐Guided Ferroptosis Therapy of TumorsAdvanced Materials, 2023
- Four Birds with One Stone: A Multifunctional Polypeptide Nanocomposite to Unify Ferroptosis, Nitric Oxide, and Photothermia for Amplifying Antitumor ImmunityAdvanced Functional Materials, 2023
- A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/ChemotherapyAdvanced Healthcare Materials, 2023
- l‐Arginine‐Modified CoWO4/FeWO4 S‐Scheme Heterojunction Enhances Ferroptosis against Solid TumorAdvanced Healthcare Materials, 2023
- Light‐Triggered Nitric Oxide Nanogenerator with High l‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal TherapyAdvanced Healthcare Materials, 2023
- Disrupting Intracellular Iron Homeostasis by Engineered Metal‐Organic Framework for Nanocatalytic Tumor Therapy in Synergy with Autophagy Amplification‐Promoted FerroptosisAdvanced Functional Materials, 2023
- Injectable Reactive Oxygen Species‐Responsive Hydrogel Dressing with Sustained Nitric Oxide Release for Bacterial Ablation and Wound HealingAdvanced Functional Materials, 2022
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019